Market Tracker

05/22 5:16pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

127.19
Delayed Data
As of May 22
 +0.31 / +0.24%
Today’s Change
55.36
Today|||52-Week Range
133.54
+40.70%
Year-to-Date

Today’s Trading

Previous close126.88
Today’s open126.26
Day’s range125.51 - 127.50
Volume773,547
Average volume (3 months)1,546,435
Market cap$20.4B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-133.09%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book12.41

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+1.70+0.65%
INCYIncyte Corp-0.72-0.66%
ZTSZoetis Inc-0.17-0.36%
HSPHospira Inc-0.04-0.05%
Data as of 4:03pm ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts